LATE-BREAKING ABSTRACT: The Sleep Apnea cardioVascular Endpoints (SAVE) study results - A trial of CPAP versus usual care in 2717 high cardiovascular risk patients with moderate-severe obstructive sleep apnea (OSA)

Conclusions: SAVE provides the first definitive randomised controlled trial evidence on the effectiveness of CPAP therapy on future CV events in patients with CV disease and co-occurring OSA.

Source: European Respiratory Journal - November 7, 2016 Category: Respiratory Medicine Authors: McEvoy, R. D., Antic, N., Heeley, E., Luo, Y., Mediano, O., McArdle, N., Tripathi, M., Lorenzi-Filho, G., Zhong, N., Anderson, C. S. Tags: 4.2 Sleep and Control of Breathing Source Type: research